Summary (tl;dr)

Over 11,000 bottles of chlorthalidone, a medication for high blood pressure, have been recalled due to "failed dissolution specifications," meaning the tablets may not dissolve correctly and could be less effective.

Essential Background

Chlorthalidone is a diuretic, commonly known as a "water pill," prescribed to manage high blood pressure (hypertension) and reduce fluid retention associated with conditions such as congestive heart failure, kidney disease, and liver disease. The drug functions by increasing the body's excretion of water, which helps to lower blood pressure.

The Full Story

A voluntary recall was initiated on June 5, 2026, by Inventia Healthcare Limited for 11,460 bottles of Chlorthalidone Tablets USP, 25 mg. The recall was prompted by the medication failing dissolution specifications during regulatory testing, indicating that the tablets might not properly disintegrate and release the active ingredient in the body. Rising Pharma Holdings Inc., based in East Brunswick, New Jersey, distributed the affected product in the U.S.. The recall includes batch numbers RISA24001 and RISB24002, both with an expiration date of April 2027. This marks the second recall of a blood pressure medication for similar dissolution issues within the last month.

Why It Matters

Patients using the recalled chlorthalidone tablets might not receive the full therapeutic dose, which could lead to ineffective blood pressure control. Unmanaged hypertension poses significant health risks, including an increased likelihood of heart disease, stroke, and other serious cardiovascular complications. The U.S. Food and Drug Administration (FDA) advises individuals not to abruptly stop taking their prescribed medication and to consult with a pharmacist or doctor for guidance on alternatives and how to proceed.

Geographic Location

• India (Chlorthalidone Tablets manufactured by Inventia Healthcare Limited)
• East Brunswick, Middlesex County, New Jersey, United States (U.S. distribution headquarters for Rising Pharma Holdings Inc.)
• United States (nationwide distribution of the recalled product)